Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ACON
ACON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ACON News
Aclarion to Present at Planet MicroCap Las Vegas 2026
Jun 10 2026
Newsfilter
Aclarion Rejects Echo Lake's Acquisition Proposal
Jun 08 2026
Newsfilter
Aclarion Stockholders Approve All Proposals at Annual Meeting
Jun 08 2026
Newsfilter
Aclarion Expands Nociscan Availability in Los Angeles Area
Jun 03 2026
Newsfilter
Aclarion Study Reveals Immune Links to Back Pain
Jun 01 2026
Newsfilter
Aclarion Responds to Echo Lake's Acquisition Proposal
May 28 2026
Newsfilter
Aclarion Partners with Weill Cornell for Lumbar Surgery Study
May 05 2026
NASDAQ.COM
ACLARION SIGNS SECOND COMMERCIAL DEAL WITH WEILL CORNELL MEDICINE
May 05 2026
moomoo
Aclarion Reports 196% Year-over-Year Growth in Nociscan Volumes for Q1 2026
May 01 2026
seekingalpha
Aclarion Appoints New Commercial Director to Drive Growth
Apr 28 2026
Newsfilter
Aclarion Announces $2.5 Million Share Repurchase Program
Apr 22 2026
seekingalpha
Aclarion Authorizes $2.5 Million Share Repurchase Program
Apr 22 2026
NASDAQ.COM
ACLARION REVEALS PARTNERSHIP WITH WEILL CORNELL MEDICINE
Apr 08 2026
moomoo
Aclarion Releases 2026 Shareholder Letter Highlighting Key Milestones
Feb 05 2026
Newsfilter
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption
Feb 04 2026
stocktwits
Aclarion Expands Nociscan Availability in Greater Los Angeles
Feb 03 2026
Newsfilter
Show More News
